Valcare Medical, Inc. announced a comprehensive corporate restructure aimed at accelerating the company's plans to initiate the AMEND clinical studies following the recent company acquisition by TechWald Holding S.p.A. As part of the restructuring, TechWald has appointed Steve Sandweg to serve as Chief Executive Officer.
Company Information
Company
Valcare Medical
Location
Herzliya, Tel Aviv, Israel
About
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve as well as the repair of the tricuspid valve.
Our breakthrough mitral valve treatment platform is based on a D-shaped ring which serves both as a docking station for Valcare’s unique replacement prosthesis, and as a highly-effective tool for mitral annulus repair.
Our mitral repair and replacement systems as well as our tricuspid repair solution establish Valcare Medical as a leader in valve care, a responsibility we very much take to heart.
HerzliyaBiotechnologyHealth CareMedicalMedical Device